Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.
Category: Publications & News
In this chapter we publish articles about Biotechgate as well as Biotech related topics. Also most of the articles published in newsletters are available here.
The Launch of the Rhine-Main-Neckar Directory
Zurich 03 March 2020 Last month Biotechgate/Venture Valuation entered a partnership with BioRN, the science and industry cluster of the Rhine-Main-Neckar region, with the goal to develop and run a publicly accessible directory of companies located in the region. The Directory has recently been launched and is accessible for free on BioRN’s website. While it … Continue reading The Launch of the Rhine-Main-Neckar Directory
How we use Big Data for curation of the Clinical Trial Database
The clinical trials database that we launched in March this year, has already grown from the initial 460,000+ records to over 500,000. It has been possible thanks to the integration with more than 13 registries around the world – a result of a Big Data project called DISCOVER in collaboration with the Swiss Institute for … Continue reading How we use Big Data for curation of the Clinical Trial Database
Partnering and match-making system with data from Biotechgate
Partnering conferences are an essential part of the business development activities in the life science industry. Our premium match-making system HelloPartnering lets conference participants plan and schedule their meetings in advance. What sets HelloPartnering apart is that data about assets and companies is populated from Biotechgate, meaning: No more “empty” company profiles in a conference … Continue reading Partnering and match-making system with data from Biotechgate
Site Selection Report for Life Sciences Companies in Europe 2018
The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five … Continue reading Site Selection Report for Life Sciences Companies in Europe 2018
Launch of a Directory of Life Sciences and Health Technologies companies with an exclusive database in Québec
Zurich / Montréal, November 26, 2018 As part of the ongoing commitment of Montréal InVivo to promote the economic development and growth of the life sciences and health technologies (LSHT) sector in Québec, Biotechgate, a company owned by Venture Valuation, and Montréal InVivo, the LSHT industrial cluster of the Montreal metropolitan area, announce a partnership … Continue reading Launch of a Directory of Life Sciences and Health Technologies companies with an exclusive database in Québec
The Antibiotics Resistance Challenge: Find Out-Licensing Opportunities and More on Biotechgate
Antibiotic resistance has become a significant problem in the global healthcare market. Over-prescribing and misuse, along with the lack of new drug development, means that both governments and the life science industry as a whole have begun to take steps to partner with or fund those companies researching infectious diseases; this is especially true for … Continue reading The Antibiotics Resistance Challenge: Find Out-Licensing Opportunities and More on Biotechgate
Site Selection for Life Sciences Companies in Europe
2015 edition The “Site Selection for Life Sciences companies in Europe” report analyzes the structure of the European life sciences landscape and looks at the strength of the Biotech, Medtech and Pharma industry of the specific market. The 2015 edition of the report includes a comparison of the following countries: Austria, Belgium, Denmark, France, Finland, … Continue reading Site Selection for Life Sciences Companies in Europe
How strong is the London-Cambridge cluster within the UK?
Our exclusive analysis we did for the Genesis conference (organized by our partner Onenucleus). Download the report >> Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more
Biotechgate starts collaboration with HTX to produce Canadian Medtech Database
Venture Valuation, the owner of Biotechgate, announces that a consortium led by The Health Technology Exchange (HTX), partnered with Biotechgate in launching a Canadian medical technology industry specific database. Click here to read the press release >>